• Health & Medicine

Researchers deploy viruses to improve cancer treatments

STAND UP TO CANCER-funded researchers are using viruses to ramp up the effectiveness of a range of cancer treatments – including immunotherapy and radiotherapy. STAND UP TO CANCER-funded researchers are using viruses to ramp up the effectiveness of a range of cancer treatments – including immunotherapy and radiotherapy.

24 October 2016

• Health & Medicine

Seeing past cancer’s invisibility cloak

Find out how our researchers are trying to reveal cancer cells for what they really are. All with the help of Stand Up To Cancer. Find out how our researchers are trying to reveal cancer cells for what they really are. All with the help of Stand Up To Cancer.

20 October 2016

• For Researchers

A new era for pancreatic cancer: The Dream Team

We catch up with Professor Gerard Evan, a cancer genetics expert in Cambridge, to hear about his Stand Up To Cancer-funded work on pancreatic cancer. We catch up with Professor Gerard Evan, a cancer genetics expert in Cambridge, to hear about his Stand Up To Cancer-funded work on pancreatic cancer.

17 October 2016

• Science & Technology
• Health & Medicine

Improving treatments for childhood nerve cancer means understanding its complexity

New research points to a possible way to help personalise treatment for a type of childhood cancer. New research points to a possible way to help personalise treatment for a type of childhood cancer.

7 October 2016

• Science & Technology
• Health & Medicine

The trans-Atlantic quest to find a winning combination of cancer drugs

An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time. An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time.

30 September 2016

• Health & Medicine

New data on cancer treatment to help improve care

Our chief clinician offers his thoughts on new data looking at one aspect of the effects of certain cancer treatments across the NHS in England. Our chief clinician offers his thoughts on new data looking at one aspect of the effects of certain cancer treatments across the NHS in England.

31 August 2016

• Health & Medicine

Immunotherapy drugs show promise in a range of advanced blood cancers

People whose blood cancer has returned after a stem-cell transplant could benefit from immunotherapy treatment, according to a preliminary US trial. People whose blood cancer has returned after a stem-cell transplant could benefit from immunotherapy treatment, according to a preliminary US trial.

14 July 2016

• Science & Technology
• Health & Medicine

Building tumours in the lab – a how to guide

Our scientists in London are taking apart tumours and rebuilding artificial versions in the lab to help test the latest treatments. Our scientists in London are taking apart tumours and rebuilding artificial versions in the lab to help test the latest treatments.

4 July 2016

• Health & Medicine

Combination immunotherapy treatment for melanoma given NHS approval

Melanoma patients in England and Wales are to become the first in Europe to benefit from a powerful combination of immunotherapy drugs. Melanoma patients in England and Wales are to become the first in Europe to benefit from a powerful combination of immunotherapy drugs.

17 June 2016

• Science & Technology
• Health & Medicine

ASCO 2016: will fine-tuning treatments require redefined tumours?

From immunotherapy to targeted cancer treatment, here's our round up of the big news from the annual ASCO conference. From immunotherapy to targeted cancer treatment, here's our round up of the big news from the annual ASCO conference.

15 June 2016

• Health & Medicine

Chemotherapy may boost immunotherapy power in ovarian cancer

Women with advanced ovarian cancer may benefit more from immunotherapy drug treatments if they are given straight after chemotherapy Women with advanced ovarian cancer may benefit more from immunotherapy drug treatments if they are given straight after chemotherapy

15 June 2016

• Health & Medicine

Genetic chaos in tumours could predict responses to immunotherapy

Advanced bladder cancers have been shown to respond to a new immunotherapy drug when used as a patient’s first treatment. Advanced bladder cancers have been shown to respond to a new immunotherapy drug when used as a patient’s first treatment.

5 June 2016